CLINICAL VALUE OF MONITORING OF PROCALCITONIN LEVEL IN BLOOD DURING ARTIFICIAL LUNG VENTILATION IN NEWBORNS WITH RESPIRATORY DISTRESS SYNDOME
https://doi.org/10.21292/2078-5658-2015-12-2-21-26
Abstract
The purpose of the trial is to assess the informative value of procalcitonin level in blood when diagnosing infectious complications of lower respiratory tract during lung ventilation in newborns with respiratory distress syndrome. The trial was designed as retrospective, observatory, one-center historical monitoring. 134 newborns were included into the trial. Ventilator-associated pneumonia was diagnosed basing on CDC/NNIS criteria. Ventilator-associated tracheobronchitis was identified basing on Code LRI-BRON criteria. Sensitivity, specificity and area under operating characteristics curve were set up for patients with different concentration of procalcitonin in order to assess the threshold diagnostic value of procalcitonin level in blood. Procalcitonin level ≥ 2.1 ng/ml in a newborn with respiratory distress syndrome by the 6th day of life proves that the patient has ventilator-associated pneumonia or tracheobronchitis.
About the Authors
P. I. Mironov
Bashkir State Medical University, Ufa
Russian Federation
Russian Federation
V. A. Rudnov
Ural State Medical University, Yekarinburg
Russian Federation
Russian Federation
References
1. Baibarina E.N., Degtyarev D.N. Prenatal medicine: from theory to practice. Ros. Vest. Perinatal. i Pediatrii. 2013, no. 5, pp. 4¬7. (In Russ.)
2. Vedeniye novorozhdenykh s respiratornym distress-syndromom: Metod. rekomend. RASPM. [Managment of newborns with respiratory distress syndrome: guidelines of Russian Association of Prenatal Medicine Specialists]. РАСПМ / Edited by V.V. Volodin, Academician of RAMS. 2014, 72 p.
3. Centers for Disease Control and Preven¬tion: Criteria for defining nosocomial pneumonia. www.cdc.gov/ncidod/hip/NNIS/members/ penumonia/Final/PneuCriteriaFinal.pdf accessed January 17, 2009.
4. Cernada M., Brugada M., Golmbek S. Ventilator¬associated pneumonia in neonatal patients: an update. Neonatology. 2014, vol. 105, pp. 98¬107.
5. Duflo F., Debon R., Monneret G. et al. Alveolar and serum procalcitonin: diagnostic and prognostic value in ventilator¬associated pneumonia. Anesthesiology. 2002, vol. 96. pp. 74¬79.
6. Elward A.M., Warren D.K., Fraser V.J. Ventilator¬associated pneumonia in pediatric intensive care unit patients: risk factors and outcomes. Pediatrics. 2002, vol. 109, pp. 758¬764.
7. Foglia E., Hollenbeak C., Fraser V. et al. Costs associated with nosocomial bloodstream infections and ventilator¬associated pneumonia in pediatric intensive care unit patients (abstract 109). 16th Annual Meet. Soc. Healthcare Epidemiol, Chicago, 2006, pp. 109.
8. Gramm H.J., Hannemann L., Reinhart K. et al. Sepsis: a conception in change. Possibilities and limitations of diagnosis based on clinical criteria. Dutch. Med. Wochenschr. 1995, vol. 120, pp. 498¬502.
9. Horan T.C. The CDC National Healthcare Safety Network (NHSN) Code LRI– BRON: lower respiratory infection¬bronchitis, tracheobronchitis, bronchiolitis, tracheitis, without evidence of pneumonia. Am. J. Infect. Control. 2008, vol. 36, pp. 309¬332.
10. Klompas M. Complications of ventilation – the CDCs new surveillance paradigm. New Engl. J. Med. 2013, vol. 368, pp. 1472¬1475.
11. Laham J.L., Breheny P.J., Gardner B.M. et al. Procalciotoni to predict bacterial coinfection in infants with acue bronchiolitis A preliminary Anallysis. Pediatric Emergency Care. 2014, vol. 30, pp. 11¬15.
12. Luyt C.E., Combes A., Reynaud C. et al. Usefulness of procalcitonin for the diagnosis of ventilator¬associated pneumonia. Int. Care Med. 2008, vol. 34, pp. 1434¬1440.
13. Magill S.S., Klompas M., Balk R. et al. Develоping a new national approach to surveillance for ventilator¬associated events: execuitive summary. Amer. J. Infect. Control. 2013, vol. 41, pp. 1096¬1099.
14. Meem M., Modak J.K., Mortuza R. et al. Biomarkers for diagnosis of neonatal infections: A systematic analysis of their potential as a point¬of¬care diagnostics. J. Global Health. 2011, vol. 1, pp. 201¬209.
15. Oppert M., Reinicke A., Muller C. et al. Elevations in procalcitonin but not C-reactive protein are associated with pneumonia after cardiopulmonary resuscitation. Resuscitation. 2002, vol. 53, pp. 167¬170.
16. Sastre J.L., Solis D.P., Seradilla V.R. et al. Procalciotoin is not sufficiently reliable to be the sole marker of neonatal sepsis of nosocomial origin. BMC Pediatrics. 2006, vol. 6, pp. 1¬7.
17. Simpson V.S., Bailey A., Higgerson R.A. et al. Ventilator¬Associated Tracheobronchitis in a Mixed Medical/Surgical Pediatric ICU. CHEST. 2013, vol. 144, pp. 32¬38.
18. Venkatachalam V., Hendley J.O., Willson F. The diagnosis dilemma of ventilator– associated pneumonia in critically ill children. Pediatr. Crit. Care Med. 2011, vol. 12, pp. 286¬296.
19. Zielinska¬Borkowska U., Skirecki T., Zlotorowicz M. et al. Procalcitonin in early onset ventilator¬associated pneumonia. J. Hosp. Infect. 2012, vol. 81, pp. 92¬97.
Review
For citations:
Mironov P.I., Rudnov V.A. CLINICAL VALUE OF MONITORING OF PROCALCITONIN LEVEL IN BLOOD DURING ARTIFICIAL LUNG VENTILATION IN NEWBORNS WITH RESPIRATORY DISTRESS SYNDOME. Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2015;12(2):21-26. (In Russ.) https://doi.org/10.21292/2078-5658-2015-12-2-21-26
Email this article 